GlassScriptPhysician profile
Jose L Ferrer
NPI 1346356243
$5,381.57
in general payments reported to CMS, 2019-2025
17 companies · $503 in 2025
The $503 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,021 · 2020: $108 · 2021: $209 · 2022: $63.81 · 2023: $356 · 2024: $121 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $781 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.17 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $3,663.07 | 2019 | |
| Janssen Biotech, INC. | $621.00 | 2019-2025 | Carvykti, Rybrevant, Erleada |
| Astellas Pharma US INC | $298.98 | 2019-2025 | |
| Urogen Pharma, INC. | $121.76 | 2023 | Jelmyto |
| Boston Scientific Corporation | $112.14 | 2023 | Rezum Generator |
| Laborie Medical Technologies Corp. | $109.98 | 2019 | |
| Pfizer Pharmaceuticals LLC | $100.25 | 2019 | |
| Abbott Laboratories | $83.83 | 2023-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $67.97 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $42.48 | 2023-2025 | Orgovyx, Gemtesa |
| Olympus America INC. | $41.18 | 2025 | Hd Camera Head, Bovie, Soltive |
| Nestle Healthcare Nutrition INC. | $24.66 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $23.29 | 2023 | |
| Daiichi Sankyo INC. | $22.81 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.98 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.59 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Ferrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.